Posch MG, Walther N, Ferrannini E, Powell DR, et al. Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study. Diabetes Care 2022 Jul 11. pii: 147215. doi: 10.2337/dc21-2166.
PMID: 35817022